ECT 4.90 Eca Marcellus Trust I $ECT Hit a 52 week low of

New Post Public Reply Private Reply Replies (0) Message Board
Emylers
ECT 4.90 Eca Marcellus Trust I $ECT Hit a 52 week low of 4.80 Closing the day 10:44 at 4.90 unch unch With a day low of 4.80 and a total volume of 51,645.

ECT Recent Posts: http://investorshangout.com/Eca-Marcellus-Trust-I-ECT-50824/

ECT Eca Marcellus Trust I Recent Headline News

ECA Marcellus Trust I - 3Q Distributions Gap Down Again
Daniel R Moore - at Seeking Alpha - Wed Nov 12, 10:24AM CST

ECT: 4.85 (-0.05)

34.0% Return Seen to Date on SmarTrend ECA Marcellus Trust Call (ECT)
Comtex SmarTrend(R) - Fri Nov 07, 4:40PM CST
SmarTrend identified a Downtrend for ECA Marcellus Trust (NYSE:ECT) on May 14th, 2014 at $7.72. In approximately 6 months, ECA Marcellus Trust has returned 34.02% as of today's recent price of $5.09.
ECT: 4.85 (-0.05)

ECA Marcellus Trust I Announces Quarterly Distribution
Business Wire - Thu Nov 06, 4:15PM CST
ECA MARCELLUS TRUST I (NYSE: ECT) announced today that the Trust's distribution for the quarter ended September 30, 2014 will be $0.203 per unit, which is expected to be distributed on or before November 28, 2014 to holders of record as of the close of business on November 21, 2014.
ECT: 4.85 (-0.05)

ECA Marcellus Trust Has Returned 32.2% Since SmarTrend Recommendation (ECT)
Comtex SmarTrend(R) - Fri Oct 24, 9:42AM CDT
SmarTrend identified a Downtrend for ECA Marcellus Trust (NYSE:ECT) on May 14th, 2014 at $7.72. In approximately 5 months, ECA Marcellus Trust has returned 32.21% as of today's recent price of $5.23.
ECT: 4.85 (-0.05)

ECA Marcellus Trust Shares Down 31.3% Since SmarTrend's Sell Call (ECT)
Comtex SmarTrend(R) - Fri Oct 17, 9:14AM CDT
SmarTrend identified a Downtrend for ECA Marcellus Trust (NYSE:ECT) on May 14th, 2014 at $7.72. In approximately 5 months, ECA Marcellus Trust has returned 31.30% as of today's recent price of $5.30.
ECT: 4.85 (-0.05)

ECA Marcellus Trust Down 34.3% Since SmarTrend Downtrend Call (ECT)
Comtex SmarTrend(R) - Thu Oct 09, 4:47PM CDT
SmarTrend identified a Downtrend for ECA Marcellus Trust (NYSE:ECT) on May 14th, 2014 at $7.72. In approximately 5 months, ECA Marcellus Trust has returned 34.28% as of today's recent price of $5.07.
ECT: 4.85 (-0.05)

Shares of ECT Down 30.0% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Thu Oct 02, 11:02AM CDT
SmarTrend identified a Downtrend for ECA Marcellus Trust (NYSE:ECT) on May 14th, 2014 at $7.72. In approximately 5 months, ECA Marcellus Trust has returned 30.01% as of today's recent price of $5.40.
ECT: 4.85 (-0.05)

ECA Marcellus Trust Shares Down 26.4% Since SmarTrend's Sell Call (ECT)
Comtex SmarTrend(R) - Thu Sep 25, 9:41AM CDT
SmarTrend identified a Downtrend for ECA Marcellus Trust (NYSE:ECT) on May 14th, 2014 at $7.72. In approximately 4 months, ECA Marcellus Trust has returned 26.38% as of today's recent price of $5.68.
ECT: 4.85 (-0.05)

Downtrend Call Working As ECA Marcellus Trust Stock Falls 20.7% (ECT)
Comtex SmarTrend(R) - Thu Sep 18, 9:17AM CDT
SmarTrend identified a Downtrend for ECA Marcellus Trust (NYSE:ECT) on May 14th, 2014 at $7.72. In approximately 4 months, ECA Marcellus Trust has returned 20.67% as of today's recent price of $6.12.
ECT: 4.85 (-0.05)

ECA Marcellus Trust Shares Down 15.5% Since SmarTrend's Sell Call (ECT)
Comtex SmarTrend(R) - Wed Sep 03, 11:08AM CDT
SmarTrend identified a Downtrend for ECA Marcellus Trust (NYSE:ECT) on May 14th, 2014 at $7.72. In approximately 4 months, ECA Marcellus Trust has returned 15.49% as of today's recent price of $6.52.
ECT: 4.85 (-0.05)

ECA Marcellus Trust Has Returned 18.3% Since SmarTrend Recommendation (ECT)
Comtex SmarTrend(R) - Wed Aug 27, 9:52AM CDT
SmarTrend identified a Downtrend for ECA Marcellus Trust (NYSE:ECT) on May 14th, 2014 at $7.72. In approximately 4 months, ECA Marcellus Trust has returned 18.34% as of today's recent price of $6.30.
ECT: 4.85 (-0.05)

ECA Marcellus Trust Down 13.5% Since SmarTrend Downtrend Call (ECT)
Comtex SmarTrend(R) - Wed Aug 20, 9:24AM CDT
SmarTrend identified a Downtrend for ECA Marcellus Trust (NYSE:ECT) on May 14th, 2014 at $7.72. In approximately 3 months, ECA Marcellus Trust has returned 13.55% as of today's recent price of $6.67.
ECT: 4.85 (-0.05)

3 Stocks With Upcoming Ex-Dividend Dates: ECT, AVA, MXIM
at The Street - Mon Aug 18, 9:00AM CDT
ECT AVA MXIM are going ex-dividend tomorrow, Tuesday, August 19, 2014
MXIM: 29.45 (+0.15), AVA: 33.80 (-0.11), ECT: 4.85 (-0.05)

ECA Marcellus Trust I declares distribution of USD0.362 per unit for quarter
M2 - Wed Feb 05, 4:36AM CST
ECA Marcellus Trust I (NYSE:ECT), an owner of royalty interests in natural gas properties owned by Energy Corporation of America, on Tuesday declared a distribution of USD0.362 per unit for the quarter ended 31 December 2013.
ECT: 4.85 (-0.05)

Zacks #5 Rank Additions for Thursday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Sep 12, 7:11AM CDT
Here are 5 stocks added to the Zacks #5 Rank ("strong sell" List for Thursday
PERI: 5.69 (-0.10), EQIX: 221.96 (-0.01), ECT: 4.85 (-0.05), NS: 57.35 (-0.34), CUTR: 10.32 (-0.02)

Zacks #5 Rank Additions for Wednesday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Sep 11, 7:09AM CDT
Here are 5 stocks added to the Zacks #5 Rank ("strong sell" List for Wednesday
CAJ: 31.21 (+0.16), CVO: 1.83 (-0.07), ECT: 4.85 (-0.05), RFP: 18.75 (+0.13), BITA: 89.61 (+10.32)

ECA Marcellus Trust I declares distribution of USD0.477 per unit for quarter
M2 - Wed Aug 07, 6:58AM CDT
ECA Marcellus Trust I (NYSE:ECT) that owns royalty interests in producing and development horizontal natural gas wells for Energy Corporation of America, on Tuesday declared a distribution of USD0.477 per unit for the quarter ended 30 June 2013.
ECT: 4.85 (-0.05)

ECA Marcellus Trust I (ECTM) Stock Research Links

ECTM Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 14

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 13

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 14

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 9

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 14

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 15

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 14

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 11

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 8

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring Telehealth Trends: A Comprehensive Yearly Insight

Updated Category News Views 346

FAIR Health's Telehealth Tracker: A Milestone Year FAIR Health has reached a significant milestone with its Monthly Telehealth Regional Tracker entering its sixth year. This tracker provides valuable insights into how telehealth usage has evolved, empowering stakeholders to understand trends in healthcare delivery. New Features and Data Insights The latest iteration of...

Continue Reading
Exploring Analog Devices: A $1000 Investment Journey

Updated Category News Views 139

The Growth of Analog Devices Inc (NASDAQ: ADI) Investors have increasingly turned their attention to Analog Devices Inc, a leader in the semiconductor industry. Over the last five years, Analog Devices has consistently outperformed the market, showcasing an annualized return of 16.0%. With a current market capitalization standing at an impressive $119.42 billion, the...

Continue Reading
Celebrating Excellence in Clinical Simulation: Meet the Nominees

Updated Category News Views 110

Highlighting Excellence in Clinical Simulation Awards A Representation of the Best in Simulation Healthcare Education in 2024 Education Management Solutions (EMS), a frontrunner in healthcare simulation and competency management platforms, has proudly announced its nominees for the 16th Annual Excellence in Clinical Simulation Awards. Each year, this noteworthy event...

Continue Reading
Significant Oil Price Drop Benefits Airlines and Cruise Lines

Updated Category News Views 195

Oil Prices Experience a Significant Drop Amid Easing Tensions Oil prices witnessed a noticeable decrease recently, plummeting over 5% during early trading in New York. This shift came as geopolitical tensions in the Middle East appeared to stabilize after an assurance from Israeli Prime Minister Benjamin Netanyahu that Iran’s oil facilities would not be targets in any...

Continue Reading
RxSight, Inc. Faces Legal Challenges: Investors Invited to Join Lawsuit

Updated Category News Views 136

RxSight, Inc. Investors Invited to Participate in Class Action Lawsuit Investors of RxSight, Inc. are becoming aware of significant opportunities to engage in a class action lawsuit. This legal action is being initiated by Bronstein, Gewirtz & Grossman, LLC, a law firm with a national reputation for advocating on behalf of investors. They are notifying shareholders that...

Continue Reading